Rallybio Corporation (RLYB) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Join SI Premium – FREE
Rallybio Corporation (NASDAQ: RLYB) reported Q4 EPS of ($0.50), $0.03 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Argan (AGX) Tops Q2 EPS by 110c
- Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
